您当前所在的位置:首页 > 产品中心 > 产品详细信息
54-11-5 分子结构
点击图片或这里关闭

3-(1-methylpyrrolidin-2-yl)pyridine

ChemBase编号:69
分子式:C10H14N2
平均质量:162.23156
单一同位素质量:162.11569846
SMILES和InChIs

SMILES:
N1(C(CCC1)c1cccnc1)C
Canonical SMILES:
CN1CCCC1c1cccnc1
InChI:
InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3
InChIKey:
SNICXCGAKADSCV-UHFFFAOYSA-N

引用这个纪录

CBID:69 http://www.chembase.cn/molecule-69.html

Collapse All Expand All

名称和登记号

名称和登记号

名称 登记号
IUPAC标准名
3-(1-methylpyrrolidin-2-yl)pyridine
IUPAC传统名
nicotine
商标名
Black Leaf
Black Leaf 40
Campbell's Nico-Soap
Commit
Destruxol Orchid Spray
Emo-Nik
Flux Maag
Fumetobac
Habitrol
Mach-Nic
Niagara P.A. Dust
Nic-Sal
Nico-Dust
Nico-Fume
Nicocide
Nicoderm
Nicoderm Cq
Nicorette
Nicorette Plus
Nicotin
Nicotina
Nicotine Polacrilex
Nicotrol
Nicotrol Inhaler
Nicotrol Ns
Nikotin
Nikotyna
Ortho N-4 Dust
Ortho N-5 Dust
Prostep
Tendust
别名
(±)-Nicotine
3-(1-Methyl-2-pyrrolidinyl)pyridine
(±)-Nicotine
(±)-3-(1-Methyl-2-pyrrolidinyl)pyridine
(R,S)-Nicotine
1-Methyl-2-(3-pyridyl)pyrrolidine
DL-Nicotine
rac-Nicotine
3-(1-methylpyrrolidin-2-yl)pyridine
L-Nicotine
Nicotine Alkaloid
Nicotine
L-1-Methyl-2-[3-pyridyl]pyrrolidine
(-)-NICOTINE FREE BASE
CAS号
54-11-5
22083-74-5
EC号
200-193-3
MDL号
MFCD00065370
Beilstein号
82108
PubChem SID
46506924
160963532
24897418
PubChem CID
942

理论计算性质

理论计算性质

JChem ALOGPS 2.1
质子受体 质子供体
LogD (pH = 5.5) -1.9628259  LogD (pH = 7.4) -0.31012845 
Log P 1.1625347  摩尔折射率 49.655 cm3
极化性 19.449343 Å3 极化表面积 16.13 Å2
可自由旋转的化学键 里宾斯基五规则 true 
Log P 0.87  LOG S -0.24 
溶解度 9.33e+01 g/l 

分子性质

分子性质

理化性质 安全信息 药理学性质 产品相关信息 生物活性(PubChem)
溶解度
1 g/mL expand 查看数据来源
Chloroform expand 查看数据来源
Ethanol expand 查看数据来源
ethanol: soluble50 mg/mL expand 查看数据来源
Methanol expand 查看数据来源
外观
Clear Colourless to Light Yellow Oil expand 查看数据来源
yellow liquid expand 查看数据来源
熔点
-79 °C expand 查看数据来源
沸点
247 °C at 745 mmHg (partial decomposition) expand 查看数据来源
67°C/0.5 mm expand 查看数据来源
闪点
101 °C expand 查看数据来源
101°C expand 查看数据来源
213.8 °F expand 查看数据来源
214 °F expand 查看数据来源
自燃点
244 °C (471 °F) expand 查看数据来源
密度
1.0097 at 20 °C (water = 1) expand 查看数据来源
1.02 g/mL at 25 °C(lit.) expand 查看数据来源
蒸汽压
0.0425 mm Hg at 20 °C expand 查看数据来源
蒸汽密度
5.6 (air = 1) expand 查看数据来源
比旋光度
[α]25/D 0°(lit.) expand 查看数据来源
疏水性(logP)
0.883 expand 查看数据来源
1.1 expand 查看数据来源
保存条件
Refrigerator expand 查看数据来源
Room Temperature (15-30°C), Desiccate, Store Under Nitrogen, Protect from light expand 查看数据来源
RTECS编号
QS5250000 expand 查看数据来源
QS5257500 expand 查看数据来源
欧盟危险性物质标志
环境危害性(Nature polluting) 环境危害性(Nature polluting) (N) expand 查看数据来源
剧毒(Highly toxic) 剧毒(Highly toxic) (T+) expand 查看数据来源
联合国危险货物编号
1654 expand 查看数据来源
MSDS下载
下载链接 expand 查看数据来源
下载链接 expand 查看数据来源
下载链接 expand 查看数据来源
德国WGK号
3 expand 查看数据来源
联合国危险货物等级
6.1 expand 查看数据来源
联合国危险货物包装类别(PG)
2 expand 查看数据来源
II expand 查看数据来源
澳大利亚Hazchem
2X expand 查看数据来源
危险公开号
25-27-51/53 expand 查看数据来源
R:25-27-51/53 expand 查看数据来源
安全公开号
36/37-45-61 expand 查看数据来源
S:45-61-36/37 expand 查看数据来源
欧盟危险货物分类
T1 expand 查看数据来源
欧盟危险识别号(EUHIN)
6.1B expand 查看数据来源
美国ERG指导号
151 expand 查看数据来源
GHS危险品标识
GHS06 expand 查看数据来源
GHS09 expand 查看数据来源
GHS警示词
Danger expand 查看数据来源
GHS危险声明
H301-H310-H411 expand 查看数据来源
GHS警示性声明
P273-P280-P301 + P310-P302 + P350-P310 expand 查看数据来源
个人保护装置
Eyeshields, Faceshields, full-face respirator (US), Gloves, multi-purpose combination respirator cartridge (US), type ABEK (EN14387) respirator filter expand 查看数据来源
RID/ADR
UN 1654 6.1/PG 2 expand 查看数据来源
相关基因信息
human ... CHRNA2(1135), CHRNA3(1136), CHRNA4(1137)rat ... Chrna3(25101), Chrna4(25590), Chrna7(25302) expand 查看数据来源
纯度
≥99% (TLC) expand 查看数据来源
≥99.0% (TLC) expand 查看数据来源
95% expand 查看数据来源
98-100% expand 查看数据来源
质检报告
下载链接 expand 查看数据来源
下载链接 expand 查看数据来源
Empirical Formula (Hill Notation)
C10H14N2 expand 查看数据来源

详细说明

详细说明

MP Biomedicals MP Biomedicals DrugBank DrugBank Sigma Aldrich Sigma Aldrich TRC TRC
MP Biomedicals -  02190671 external link
Free Base
Purity: 98-100% (~ 6.22M)
Clear light yellow liquid
DrugBank -  DB00184 external link
Item Information
Drug Groups approved
Description Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke. [PubChem]
Indication For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.
Pharmacology Nicotine, the primary alkaloid in tobacco products binds stereo-selectively to nicotinic-cholinergic receptors on autonomic ganglia, the adrenal medulla, neuromuscular junctions and in the brain. Nicotine exerts two effects, a stimulant effect exerted at the locus ceruleus and a reward effect in the limbic system. Itranvenous administration of nicotine causes release of acetylcholine, norepinephrine, dopamine, serotonine, vasopressin, beta-endorphin and ACTH. Nicotine is a highly addictive substance. Nicotine also induces peripheral vasoconstriction, tachycardia and elevated blood pressure. Nicotine inhalers and patches are used to treat smoking withdrawl syndrome. Nicotine is classified as a stimulant of autonomic ganglia.
Toxicity Symptoms of overdose include nausea, abdominal pain, vomiting, diarrhea, diaphoresis, flushing, dizziness, disturbed hearing and vision, confusion, weakness, palpitations, altered respiration and hypotension. LD50= 24 mg/kg (orally in mice).
Affected Organisms
Humans and other mammals
Biotransformation Primarily hepatic, cotinine is the primary metabolite.
Absorption Absorption of nicotine through the buccal mucosa is relatively slow and the high and rapid rise followed by the decline in nicotine arterial plasma concentrations seen with cigarette smoking are not achieved with the inhaler. About 10% of absorbed nicotine is excreted unchanged in urine.
Half Life Cotinine has a half life of 15-20 hours, while nicotine has a half life of 1-3 hours
Protein Binding Less than 5%
Elimination About 10% of the nicotine absorbed is excreted unchanged in the urine.
Distribution * 2 to 3 L/kg
Clearance * 1.2 L/min [healthy adult smoker]
References
Nolley EP, Kelley BM: Adolescent reward system perseveration due to nicotine: studies with methylphenidate. Neurotoxicol Teratol. 2007 Jan-Feb;29(1):47-56. Epub 2006 Oct 4. [Pubmed]
de Leon J, Tracy J, McCann E, McGrory A, Diaz FJ: Schizophrenia and tobacco smoking: a replication study in another US psychiatric hospital. Schizophr Res. 2002 Jul 1;56(1-2):55-65. [Pubmed]
de Leon J, Dadvand M, Canuso C, White AO, Stanilla JK, Simpson GM: Schizophrenia and smoking: an epidemiological survey in a state hospital. Am J Psychiatry. 1995 Mar;152(3):453-5. [Pubmed]
Aguilar MC, Gurpegui M, Diaz FJ, de Leon J: Nicotine dependence and symptoms in schizophrenia: naturalistic study of complex interactions. Br J Psychiatry. 2005 Mar;186:215-21. [Pubmed]
External Links
Wikipedia
RxList
PDRhealth
Drugs.com
Sigma Aldrich -  N0267 external link
Biochem/physiol Actions
Prototype nicotinic acetylcholine receptor agonist.
Other Notes
Tandem Mass Spectrometry data independently generated by Scripps Center for Metabolomics is available to view or download in PDF. N0267.pdf Tested metabolites are featured on Scripps Center for Metabolomics METLIN Metabolite Database. To learn more, visit sigma.com/metlin.
Tandem Mass Spectrometry data independently generated by Scripps Center for Metabolomics is available to view or download in PDF. N0267.pdf Tested metabolites are featured on Scripps Center for Metabolomics METLIN Metabolite Database. To learn more, visit sigma.com/metlin.
Toronto Research Chemicals -  N412420 external link
Nicotine is an alkaloid isolated from plants. Nicotine is an active stimulant, having both addictive and carcinogenic properties. Nicotine can be absorbed through the alimentary canal, respiratory tract and intact skin. Nicotine is used in the treatment o

参考文献

参考文献

供应商提供 Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • Nolley EP, Kelley BM: Adolescent reward system perseveration due to nicotine: studies with methylphenidate. Neurotoxicol Teratol. 2007 Jan-Feb;29(1):47-56. Epub 2006 Oct 4. Pubmed
  • de Leon J, Tracy J, McCann E, McGrory A, Diaz FJ: Schizophrenia and tobacco smoking: a replication study in another US psychiatric hospital. Schizophr Res. 2002 Jul 1;56(1-2):55-65. Pubmed
  • de Leon J, Dadvand M, Canuso C, White AO, Stanilla JK, Simpson GM: Schizophrenia and smoking: an epidemiological survey in a state hospital. Am J Psychiatry. 1995 Mar;152(3):453-5. Pubmed
  • Aguilar MC, Gurpegui M, Diaz FJ, de Leon J: Nicotine dependence and symptoms in schizophrenia: naturalistic study of complex interactions. Br J Psychiatry. 2005 Mar;186:215-21. Pubmed
  • Ferretti, G., et al.: J. Med. Chem., 45, 4724 (2002)
  • Guillen, M., et al.: J. Agric. Food Chem., 53, 1093 (2002)
  • Ramunno, A., et al.: Bioorg. Med. Chem. Lett., 15, 3237 (2002)
  • Alburges, M., et al.: Eur. J. Pharmacol., 573, 124 (2002)
正在搜索,请耐心等待...(如果遇到网页错误或者长时间没有结果,请刷新页面[F5])

专利

专利

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

互联网资源

互联网资源

百度图标百度 google iconGoogle